Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Prostate Artery Embolization for Symptomatic Benign Prostatic Hyperplasia

NCT02822924 is registered in ClinicalTrials.gov with Chinese University of Hong Kong as lead sponsor.

NCT NCT02822924
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02822924 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Prostate Artery Embolization for Symptomatic Benign Prostatic Hyperplasia
Lead sponsor
Chinese University of Hong Kong
Phase
Not applicable
Overall status
Completed
Start date
October 7, 2013
Completion date
March 10, 2021
Enrollment
82 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

benign prostate hyperplasia